PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.

Ferdosi SR, Taylor B, Lee M, Tang N, Peng S, Bybee R, Reid G, Hartman L, Garcia-Mansfield K, Sharma R, Pirrotte P, Ma J, Parisian AD, Furnari F, Dhruv HD, Berens ME

Open source

DOI: 10.1093/neuonc/noac067
Published: 2022 Nov 2
Container: Neuro-oncology
Publisher: Not recorded
Open access: yes

Credibility signals

serious concern Score 10/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
serious concernRetraction Watch retraction: 1 retraction notice matched this DOI. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1093/neuonc/noac067,
  title = {PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.},
  author = {Ferdosi SR and Taylor B and Lee M and Tang N and Peng S and Bybee R and Reid G and Hartman L and Garcia-Mansfield K and Sharma R and Pirrotte P and Ma J and Parisian AD and Furnari F and Dhruv HD and Berens ME},
  year = {2022},
  journal = {Neuro-oncology},
  doi = {10.1093/neuonc/noac067},
  url = {https://doi.org/10.1093/neuonc/noac067}
}

RIS

TY  - JOUR
TI  - PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.
AU  - Ferdosi SR
AU  - Taylor B
AU  - Lee M
AU  - Tang N
AU  - Peng S
AU  - Bybee R
AU  - Reid G
AU  - Hartman L
AU  - Garcia-Mansfield K
AU  - Sharma R
AU  - Pirrotte P
AU  - Ma J
AU  - Parisian AD
AU  - Furnari F
AU  - Dhruv HD
AU  - Berens ME
PY  - 2022
JO  - Neuro-oncology
DO  - 10.1093/neuonc/noac067
UR  - https://doi.org/10.1093/neuonc/noac067
ER  -

APA

SR, F., B, T., M, L., N, T., S, P., R, B., G, R., L, H., K, G., R, S., P, P., J, M., AD, P., F, F., HD, D., & ME, B. (2022). PTEN loss drives resistance to the neddylation inhibitor MLN4924 in glioblastoma and can be overcome with TOP2A inhibitors.. Neuro-oncology. https://doi.org/10.1093/neuonc/noac067

Source records

pubmed · retrieved 2026-09-25T08:42:58.090Z